Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
26.7M
-
Shares change
-
+3.46M
-
Total reported value, excl. options
-
$143M
-
Value change
-
+$18.6M
-
Number of buys
-
44
-
Number of sells
-
-32
-
Price
-
$5.35
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2018
86 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q2 2018.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.7M shares
of 44.7M outstanding shares and own 59.82% of the company stock.
Largest 10 shareholders include First Light Asset Management, LLC (5.95M shares), BlackRock Inc. (2.93M shares), DIMENSIONAL FUND ADVISORS LP (1.94M shares), ROYCE & ASSOCIATES LP (1.57M shares), VANGUARD GROUP INC (1.56M shares), HEARTLAND ADVISORS INC (1.39M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.08M shares), SEGALL BRYANT & HAMILL, LLC (972K shares), ACADIAN ASSET MANAGEMENT LLC (853K shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (770K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.